Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 EP394 | DOI: 10.1530/endoabs.81.EP394

National Institute of Nutrition, Department C, Tunis, Tunisia


Introduction: The association of hypertension and type 2 diabetes is frequent. These two pathologies constitute each a cardiovascular risk factor with a cumulative effect which increases the cardiovascular morbi-mortality of hypertensive diabetics.

Objective: To measure and compare the frequency of degenerative complications of diabetes in hypertensive and non-hypertensive diabetics.

Patients and method: The study was descriptive, retrospective and included 184 type 2 diabetic patients followed at the service C of the National Institute of Nutrition of Tunis.

Results: The mean age was 61±10 years, with a sex ratio M/F of 0.56. The mean duration of diabetes was 14±8 years, the mean glycated hemoglobin (HbA1c) was 10.6%. It was noted that 69.5% of patients had hypertension. The prevalence of microangiopathy was globally higher in hypertensive diabetics than in non-hypertensive patients (retinopathy: 33.6% vs 8.9%; neuropathy: 26.6% vs 17.8%; nephropathy: 43% vs 3.6%). Similarly, the prevalence of macroangiopathies was higher in hypertensive diabetics (stroke: 3.9% versus 0.54%; coronary artery disease: 18.8% versus 1.6%; and cerebral artery disease: 6.3% versus 1.8%).

Conclusion: Hypertension is often associated with type 2 diabetes. It worsens the cardiovascular prognosis and accelerates the onset of degenerative complications. Adequate management of arterial hypertension is therefore necessary to reduce the cardiovascular risk of diabetic patients.

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts